What is the recommended infusion time for ceftazidime administration?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 20, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Ceftazidime Infusion Time

Ceftazidime should be administered intravenously over 20 to 30 minutes for standard intermittent dosing.

Standard Administration

The FDA-approved infusion time for ceftazidime is 20-30 minutes for intermittent IV administration 1. This applies to all standard doses (500 mg, 1 g, and 2 g). After infusion over this timeframe, mean peak serum concentrations of 42,69, and 170 mcg/mL are achieved for 500-mg, 1-g, and 2-g doses, respectively 1.

Bolus administration over 5 minutes is also FDA-approved and achieves slightly higher peak concentrations (45 and 90 mcg/mL for 500-mg and 1-g doses), though the 20-30 minute infusion is more commonly used in practice 1.

Extended and Continuous Infusion Options

For critically ill patients, particularly those with severe infections or augmented renal clearance, extended or continuous infusion should be strongly considered 2:

  • Extended infusion: Administer over 3-4 hours to optimize time above MIC for bacteria with higher MICs
  • Continuous infusion: After a loading dose, maintain steady-state concentrations with 24-hour infusion

Evidence for Extended Infusion

Recent French critical care guidelines recommend extended or continuous infusion of beta-lactams in ICU patients with obesity to increase the likelihood of therapeutic drug concentrations 2. Multiple studies demonstrate that:

  • 3-4 hour infusions maintain ceftazidime concentrations above the MIC for 92-100% of the dosing interval against Pseudomonas aeruginosa 3
  • Continuous infusion (3 g/24 hours after loading dose) maintains steady-state concentrations of approximately 30 mcg/mL, well above typical MICs 4, 3
  • Clinical efficacy is equivalent between continuous and intermittent dosing, but continuous infusion optimizes pharmacodynamics and uses less total antibiotic 5

Practical Continuous Infusion Protocol

For continuous infusion 4, 6:

  1. Give 500 mg IV bolus over 2 minutes as loading dose
  2. Follow immediately with 3 g continuous infusion over 24 hours
  3. Use ice packs with elastomeric infusion devices to maintain stability
  4. Target steady-state concentration: 15-30 mcg/mL

Pediatric Considerations

The same 20-30 minute infusion time applies to pediatric patients receiving standard intermittent dosing 7, 8. Continuous infusion has been successfully used in cystic fibrosis children with comparable clinical outcomes to intermittent dosing 6.

Key Clinical Pitfalls

  • Do not mix with vancomycin: Physical incompatibility occurs; flush IV lines between administration 1
  • Renal adjustment required: Patients with creatinine clearance <70 mL/min need dose/interval adjustment, but infusion time remains 20-30 minutes 1
  • Stability concerns: Once reconstituted, ceftazidime maintains potency for 12 hours at room temperature or 3 days refrigerated 1
  • Consider extended infusion for: Pseudomonas infections, critically ill patients, augmented renal clearance, or when MIC approaches breakpoint (≥8 mg/L) 2, 9

References

Research

Continuous infusion of ceftazidime with an elastomeric infusion device.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1998

Related Questions

What is the recommended ceftazidime dosage for an adult with a chest infection and normal renal function?
What is the proper technique for administering a ceftazidime lock to a permanent tunneled hemodialysis catheter?
Is there published data supporting extended or prolonged infusion of ceftazidime in critically ill adults with severe Gram‑negative infections such as ventilator‑associated pneumonia, bloodstream infection, or intra‑abdominal sepsis?
How is ceftazidime administered, and what are its dosing guidelines, renal dose adjustments, contraindications, and monitoring recommendations?
What is the recommended ceftazidime dose for a newborn, including weight‑based dosing and age considerations?
What should the insulin‑to‑carbohydrate ratio and insulin glargine (Lantus) dose be for a 40‑year‑old male with pancreatogenic (type 3c) diabetes weighing 67 kg, who is currently using a 1 U per 12 g carbohydrate ratio and 18 U of insulin glargine daily, given his pattern of hyperglycemia after meals and overnight?
What are the likely causes of fresh rectal bleeding in an 80-year-old patient?
What sleep‑related side effects are associated with GHK‑Cu (glycyl‑L‑histidyl‑L‑lysine copper peptide)?
In a 22-year-old female with hemoglobin 12.2 g/dL, hematocrit 35.9 %, serum iron 88 µg/dL, and ferritin 30.8 ng/mL, is this iron‑deficiency anemia?
What are the recommended dosing, monitoring, and safety considerations when using a mixture of propofol, fentanyl, and midazolam (Versed) for procedural sedation?
Can a patient on pembrolizumab (Keytruda) combined with carboplatin and docetaxel safely receive the shingles vaccine and the pneumococcal vaccine, and undergo a colonoscopy during treatment?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.